These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 31304632)

  • 1. Transcriptional regulation of normal human mammary cell heterogeneity and its perturbation in breast cancer.
    Pellacani D; Tan S; Lefort S; Eaves CJ
    EMBO J; 2019 Jul; 38(14):e100330. PubMed ID: 31304632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic and Transcriptomic Profiling of Mammary Gland Development and Tumor Models Disclose Regulators of Cell State Plasticity.
    Dravis C; Chung CY; Lytle NK; Herrera-Valdez J; Luna G; Trejo CL; Reya T; Wahl GM
    Cancer Cell; 2018 Sep; 34(3):466-482.e6. PubMed ID: 30174241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes.
    Prat A; Karginova O; Parker JS; Fan C; He X; Bixby L; Harrell JC; Roman E; Adamo B; Troester M; Perou CM
    Breast Cancer Res Treat; 2013 Nov; 142(2):237-55. PubMed ID: 24162158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas.
    Chan SR; Vermi W; Luo J; Lucini L; Rickert C; Fowler AM; Lonardi S; Arthur C; Young LJ; Levy DE; Welch MJ; Cardiff RD; Schreiber RD
    Breast Cancer Res; 2012 Jan; 14(1):R16. PubMed ID: 22264274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting the transcriptional networks underlying breast cancer: NR4A1 reduces the migration of normal and breast cancer cell lines.
    Alexopoulou AN; Leao M; Caballero OL; Da Silva L; Reid L; Lakhani SR; Simpson AJ; Marshall JF; Neville AM; Jat PS
    Breast Cancer Res; 2010; 12(4):R51. PubMed ID: 20642837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
    Zuo Y; Ulu A; Chang JT; Frost JA
    Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Gene Expression Signatures for the Identification of Cellular Heterogeneity in the Developing Mammary Gland.
    Henry S; Trousdell MC; Cyrill SL; Zhao Y; Feigman MJ; Bouhuis JM; Aylard DA; Siepel A; Dos Santos CO
    J Mammary Gland Biol Neoplasia; 2021 Mar; 26(1):43-66. PubMed ID: 33988830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TOX3 is expressed in mammary ER(+) epithelial cells and regulates ER target genes in luminal breast cancer.
    Seksenyan A; Kadavallore A; Walts AE; de la Torre B; Berel D; Strom SP; Aliahmad P; Funari VA; Kaye J
    BMC Cancer; 2015 Jan; 15():22. PubMed ID: 25632947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting the heterogeneity and tumorigenesis of BRCA1 deficient mammary tumors via single cell RNA sequencing.
    Sun H; Zeng J; Miao Z; Lei KC; Huang C; Hu L; Su SM; Chan UI; Miao K; Zhang X; Zhang A; Guo S; Chen S; Meng Y; Deng M; Hao W; Lei H; Lin Y; Yang Z; Tang D; Wong KH; Zhang XD; Xu X; Deng CX
    Theranostics; 2021; 11(20):9967-9987. PubMed ID: 34815798
    [No Abstract]   [Full Text] [Related]  

  • 10. The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment.
    Turpin J; Ling C; Crosby EJ; Hartman ZC; Simond AM; Chodosh LA; Rennhack JP; Andrechek ER; Ozcelik J; Hallett M; Mills GB; Cardiff RD; Gray JW; Griffith OL; Muller WJ
    Oncogene; 2016 Nov; 35(47):6053-6064. PubMed ID: 27157621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-color clonal tracking reveals intra-stage proliferative heterogeneity during mammary tumor progression.
    Tiede S; Kalathur RKR; Lüönd F; von Allmen L; Szczerba BM; Hess M; Vlajnic T; Müller B; Canales Murillo J; Aceto N; Christofori G
    Oncogene; 2021 Jan; 40(1):12-27. PubMed ID: 33046799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage.
    Zhu M; Yi M; Kim CH; Deng C; Li Y; Medina D; Stephens RM; Green JE
    Genome Biol; 2011 Aug; 12(8):R77. PubMed ID: 21846369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-tumor heterogeneity in breast cancer has limited impact on transcriptomic-based molecular profiling.
    Karthik GM; Rantalainen M; Stålhammar G; Lövrot J; Ullah I; Alkodsi A; Ma R; Wedlund L; Lindberg J; Frisell J; Bergh J; Hartman J
    BMC Cancer; 2017 Nov; 17(1):802. PubMed ID: 29187174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological subtypes of mouse mammary tumors reveal conserved relationships to human cancers.
    Hollern DP; Swiatnicki MR; Andrechek ER
    PLoS Genet; 2018 Jan; 14(1):e1007135. PubMed ID: 29346386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer.
    Aydoğdu E; Katchy A; Tsouko E; Lin CY; Haldosén LA; Helguero L; Williams C
    Carcinogenesis; 2012 Aug; 33(8):1502-11. PubMed ID: 22562546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MTA family of transcriptional metaregulators in mammary gland morphogenesis and breast cancer.
    Singh RR; Kumar R
    J Mammary Gland Biol Neoplasia; 2007 Sep; 12(2-3):115-25. PubMed ID: 17549610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toca-1 is suppressed by p53 to limit breast cancer cell invasion and tumor metastasis.
    Chander H; Brien CD; Truesdell P; Watt K; Meens J; Schick C; Germain D; Craig AW
    Breast Cancer Res; 2014 Dec; 16(6):3413. PubMed ID: 25547174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional changes associated with breast cancer occur as normal human mammary epithelial cells overcome senescence barriers and become immortalized.
    Li Y; Pan J; Li JL; Lee JH; Tunkey C; Saraf K; Garbe JC; Whitley MZ; Jelinsky SA; Stampfer MR; Haney SA
    Mol Cancer; 2007 Jan; 6():7. PubMed ID: 17233903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embryonic mammary signature subsets are activated in Brca1-/- and basal-like breast cancers.
    Zvelebil M; Oliemuller E; Gao Q; Wansbury O; Mackay A; Kendrick H; Smalley MJ; Reis-Filho JS; Howard BA
    Breast Cancer Res; 2013 Mar; 15(2):R25. PubMed ID: 23506684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1.
    Wright MH; Robles AI; Herschkowitz JI; Hollingshead MG; Anver MR; Perou CM; Varticovski L
    Mol Cancer; 2008 Apr; 7():29. PubMed ID: 18394172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.